CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and placebo in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC).This study aims to explore whether blockade of Transforming Gr...
Phase 3
Salt Lake City, Utah, United States and 113 other locations
and capecitabine monotherapy in patients with metastatic pancreatic adenocarcinoma whose disease has not progressed on a first line fluoropy...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 18 other locations
The purpose of this study is to evaluate the efficacy of zolbetuximab plus capecitabine and oxaliplatin (CAPOX) compared with placebo plus CAPOX (as...
Phase 3
Salt Lake City, Utah, United States and 164 other locations
participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 67 other locations
The purpose of this study is to confirm the recommended phase 2 dose (RP2D) of zolbetuximab in combination with Nab-P + GEM, determine overall surviv...
Phase 2
Salt Lake City, Utah, United States and 137 other locations
This study is being done to see if tucatinib with trastuzumab, ramucirumab and paclitaxel works better than ramucirumab and paclitaxel to treat HER2-...
Phase 2, Phase 3
Salt Lake City, Utah, United States and 47 other locations
Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...
Salt Lake City, Utah, United States and 37 other locations
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer
Phase 2
Salt Lake City, Utah, United States and 16 other locations
and efficacy of avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 10 other locations
untreated adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma.The primary study hypotheses are that:Neoadjuvant and adjuv...
Phase 3
Salt Lake City, Utah, United States and 170 other locations
Clinical trials
Research sites
Resources
Legal